BEIGF
BeOne Medicines AG SHANGHAI STOCK EXCHA$22.50
Mkt Cap $33.2B
CNY
52w Low $213.33
-143.8% of range
52w High $346.00
P/E (TTM)
8.6x
EV/EBITDA
0.0x
P/B
7.3x
Debt/Equity
0.2x
ROE
6.6%
P/FCF
0.0x
RSI (14)
—
ATR (14)
—
Beta
0.64
50d MA
—
200d MA
—
Avg Volume
3.4M
Recent Filings
8-K
Unknown — 8-K Filing
BEIGF's annual report availability only in Chinese suggests limited English-language transparency, potentially raising concerns for Western investors about information access and corporate governance standards.
Apr 14
8-K
BeOne Medicines AG -- 8-K Filing
I cannot provide a meaningful analysis of this filing as the summary lacks substantive information about a specific corporate event, transaction, or material development that would impact investor decisions.
Feb 26
Data updated apr 27, 2026 7:55pm
· Source: massive.com